multicenter
Showing 9976 - 10000 of >10,000
Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)
Terminated
- Advanced BRAFV600 Wild-type Melanoma
- Cobimetinib
- +2 more
-
Tucson, Arizona
- +120 more
Aug 24, 2022
Cardiovascular, Pulmonary, and Integrative Functional Phenotypes
Recruiting
- Covid19
- Fenofibrate
- Placebo
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 18, 2022
COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)
Completed
- COVID
- +3 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- +2 more
-
Colorado Springs, Colorado
- +38 more
Mar 31, 2022
Semantic and Syntactic Computerized Analysis of Free Speech
Recruiting
- Psychotic Disorders
- +4 more
-
Brest, France
- +2 more
Jun 3, 2022
HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,
Recruiting
- HER2-positive Breast Cancer
- +4 more
-
Essen, Germany
- +5 more
Nov 15, 2022
Bladder Hyperactivity Trial in France (Device: INTERSTIM II)
Completed
- Bladder Hyperactivity
- Device: INTERSTIM II
-
Caen, France
- +11 more
Jun 26, 2020
Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Durvalumab
- +2 more
-
Little Rock, Arkansas
- +34 more
Aug 4, 2021
Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD) Trial in Puerto Rico, United States (Cariprazine Flexible
Recruiting
- Schizophrenia
- +2 more
- Cariprazine Flexible Dose
-
Dothan, Alabama
- +32 more
Aug 8, 2022
Pancreatic Cancer Trial in Shanghai (IN10018, Albumin-Bound Paclitaxel, Gemcitabine)
Recruiting
- Pancreatic Cancer
- IN10018
- +3 more
-
Shanghai, Shanghai, ChinaRenji Hospital of Shanghai Jiaotong University School of Medicin
Apr 23, 2023
d to Support Short Fixed Bridges With Immediate Occlusal
Completed
- Partial Edentulism
- Tooth Disease
-
Los Angeles, CaliforniaUniversity of Southern California
Mar 24, 2022
ive Briviact is as add-on Treatment for Epilepsy With Partial
Completed
- Epilepsy With POS With or Without Secondary Generalization
-
Aarhus, Denmark
- +43 more
Jul 12, 2021
Typhoid Trial in Nepal (Test Vaccine Vi-DT Typhoid conjugate, Control Vaccine Typbar TCV®)
Unknown status
- Typhoid
- Test Vaccine Vi-DT Typhoid conjugate
- Control Vaccine Typbar TCV®
-
Banke, City- Nepalgunj, Nepal
- +3 more
Apr 21, 2020
Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (AK002, Placebo)
Recruiting
- Eosinophilic Gastritis
- Eosinophilic Duodenitis
- AK002
- Placebo
-
Birmingham, Alabama
- +73 more
Dec 9, 2021
Esophageal Cancer Trial (BIRC3)
Not yet recruiting
- Esophageal Cancer
- BIRC3
- (no location specified)
Apr 16, 2020
Primary Open-angle Glaucoma, Ocular Hypertension Trial in Guangzhou (Levobetaxolol eye drops, Betaxolol eye drops)
Unknown status
- Primary Open-angle Glaucoma
- Ocular Hypertension
- Levobetaxolol eye drops
- Betaxolol eye drops
-
Guangzhou, Guangdong, ChinaZhongshan ophthalmic center, Sun Yat-sen University
May 6, 2020
Biliary Tract Cancer Trial in Worldwide (Varlitinib, Capecitabine, Placebo (for Varlitinib))
Metastatic Breast Cancer Trial in San Francisco, Durham, Nashville (PLX3397, Eribulin)
Completed
- Metastatic Breast Cancer
-
San Francisco, California
- +2 more
Jul 2, 2020
Hereditary Angioedema (HAE) Trial in Worldwide (CINRYZE with rHuPH20)
Completed
- Hereditary Angioedema (HAE)
- CINRYZE with rHuPH20
-
Birmingham, Alabama
- +22 more
May 11, 2021
Obesity, Diabetes Trial in France (Gastric By-Pass, optimized medical management)
Recruiting
- Obesity
- Diabetes
- Gastric By-Pass
- optimized medical management
-
Lille, Nord, France
- +9 more
Sep 10, 2020
Small Cell Lung Cancer (SCLC) Trial in France, Italy, United Kingdom (Pembrolizumab, cis/carboplatin and etoposide)
Active, not recruiting
- Small Cell Lung Cancer (SCLC)
- Pembrolizumab
- cis/carboplatin and etoposide
-
Avignon, France
- +18 more
May 9, 2022
Scleroderma, Systemic, Sclerosis, Autoimmune Disease Trial in Canada, United States (mHSCT, cyclophosphamide)
Completed
- Scleroderma, Systemic
- +2 more
- mHSCT
- cyclophosphamide
-
Duarte, California
- +16 more
May 12, 2021
Analgesia Trial in Hebei (Butorphanol and Propofol, Fentanyl and Propofol)
Unknown status
- Analgesia
- Butorphanol and Propofol
- Fentanyl and Propofol
-
Hebei, Hebei, ChinaHebei People's Hospital
Mar 18, 2020